Abbvie Inc. vs Medtronic plc
ABBV vs MDT — side-by-side comparison from reported financials. ABBV leads 4, MDT leads 6 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Medtronic plc
MDT · Healthcare
$88.01+0.30%Mixed
| Metric | ABBV | MDT |
|---|---|---|
| Price | $276.43 | $88.01 |
| Market cap | $488B | $113B |
| Revenue (TTM) | $64.4B | $37.5B |
| Revenue growth | +1.8% | +5.2% |
| Net margin | 9.8% | 13.9% |
| Free cash flow | $18.2B | $6.13B |
| Net cash (debt) | ($56.2B) | — |
| 1-year price return | +19.8% | -8.8% |
| P/E | 77.4 | 21.6 |
| P/E vs own history (cheap-side %) | 23% | 96% |
| Dividend yield | 2.45% | 3.22% |
| Return on equity | 96% | 11% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 95,000 |
Full résumé-style profiles: ABBV CV · MDT CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.